IC
TNYA icon

IEQ Capital’s Tenaya Therapeutics TNYA Stock Holding History

IEQ Capital’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,686
Closed -$38.4K – 2013
2025
Q3 		$38.4K Sell
23,686
-159,766
-87% -$161K ﹤0.01% 1808
2025
Q2 		$112K Buy
183,452
+16,132
+10% +$8.21K ﹤0.01% 1705
2025
Q1 		$95.4K Buy
+167,320
New +$165K ﹤0.01% 1485

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM

IEQ Capital's TNYA Position: Q4 2025 in Review

IEQ Capital sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 23,686 shares — an estimated $38.4K sold.

IEQ Capital first reported a position in TNYA in Q1 2025 and held it in 3 quarters. The position peaked at $112K in Q2 2025. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • IEQ Capital reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
  • IEQ Capital sold 23,686 Tenaya Therapeutics shares in Q4 2025, an estimated $38.4K.
  • IEQ Capital first reported a position in Tenaya Therapeutics in Q1 2025 and held it in 3 quarters.
  • IEQ Capital's Tenaya Therapeutics position peaked at $112K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on IEQ Capital's 13F filing for Q4 2025, filed 13 Feb 2026.